Riskpilot← Back to searchSign inGet full accessCordane ApS
APSActiveCVR 39274698Sundvænget 10Manufacture of pharmaceutical preparations · NACE 2120Est. 2018— employees
Revenue 2024
DKK -33K
-15% vs 2023
EBITDA margin
100.0%
+15% vs 2023
Equity ratio
73.6%
Financial strength
Net profit 2024
DKK -33K
+15% vs 2023
| Revenue | DKK -33K | -15% |
| EBITDA | DKK -33K | +15% |
| Net profit | DKK -33K | +15% |
| Total assets | DKK 2M | +0% |
| Equity | DKK 1,5M | -2% |
| Employees | — | — |
Legal name
Cordane ApS
CVR number
39274698
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
24. januar 2018
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør
Company purpose
Selskabets formål er at udvikle og kommercialisere farmaceutiske lægemidler og dermed forbunden virksomhed.
Address
Sundvænget 10
Phone
+4528403916
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | -16 | -9 | 1.990 | -29 | -38 | -33 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 0 | -16 | -9 | 1.990 | -29 | -38 | -33 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 0 | -16 | -9 | 1.990 | -29 | -38 | -33 |
| Net financials | 0 | 0 | -1 | -0 | -0 | 0 | -0 |
| Profit before tax | 0 | -16 | -10 | 1.990 | -29 | -38 | -33 |
| Tax | -0 | -0 | -0 | 432 | -0 | -0 | -0 |
| Net profit | 0 | -16 | -10 | 1.558 | -29 | -38 | -33 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 40 | 2.040 | 2.000 | 2.000 | 2.000 |
| Equity | 0 | -16 | -27 | 1.571 | 1.542 | 1.504 | 1.471 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 17 | 67 | 469 | 458 | 496 | 529 |
| Total debt | 0 | 17 | 67 | 469 | 458 | 496 | 529 |
EBITDA margin
-3264100.0%
This company
15.8%
Market median
-20658961% vs market
20182024
Equity ratio
73.6%
This company
38.2%
Market median
+93% vs market
20182024
Return on equity
-2.2%
This company
18.4%
Market median
-112% vs market
20182024
Net profit margin
-3264200.0%
This company
8.1%
Market median
-40298865% vs market
20182024
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20182024
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-24 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SA Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
LJ Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CHRISJOPALI ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CHRISJOPALI ApS
Cordane ApS Board members of Cordane ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svend Aage Johansen | Chief Executive Officer | 0 companies |
| Lisbet Johansen | Chief Executive Officer | 0 companies |